ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
40 announcements with these filters
Anlon Healthcare's board approved incorporation of two subsidiaries, investing up to Rs 1.75 million (₹0.175 Crore). The company will hold 55% and 65% equity respectively.
Anlon Healthcare Ltd reported revenue from operations of ₹33.3 Cr (-11.9% YoY) and net profit of ₹3.5 Cr (-7.9% YoY) for Q1 FY26.
Anlon Healthcare's Chairman and Managing Director participated in a media interview on Money TV. The discussion focused on FY 2025-26 performance and industry outlook.
Anlon Healthcare Limited reported FY26 consolidated total income of ₹172.22 Cr, up 42.98% YoY. Strategy focuses on API expansion and CDMO scaling.
Anlon Healthcare reports strong FY26 growth with revenues reaching ₹171.97cr, up from ₹120.29cr in FY25. Strategy focuses on backward integration and expansion via Bizotic and Apiqo acquisitions.
Anlon Healthcare reported FY26 consolidated revenue of ₹172.22 Crore, a 43% year-on-year increase. PAT grew 42% to ₹29.09 Crore, driven by strategic acquisitions and API demand.
Anlon Healthcare Ltd reported revenue from operations of ₹50.9 Cr (+4.1% YoY) and net profit of ₹11.1 Cr (-33.1% YoY) for Q4 FY26.
Anlon Healthcare approved audited FY26 financial results showing standalone total income of ₹176.75 Crore. The board also reviewed issue proceeds utilization and audit reports.
Anlon Healthcare Limited scheduled a board meeting for May 29, 2026. The board will consider audited standalone and consolidated financial results for fiscal year 2026.
Anlon Healthcare Limited reported the full utilization of its ₹121.03 Crore IPO proceeds. The report confirms alignment with shareholder-approved objects including facility expansion and acquisitions.